1658
X.-P. Hui et al.
CH3CH2CH2), 2.94 (t, 2H, J ¼ 7.2 Hz, CH3CH2 CH2), 3.97 (s, 2H, SCH2),
7.62 (s, 5H, ArH); IR (cm21) (KBr disc): 3051 (w, ArH), 2959, 2900
(w, CH3, CH2), 1578 (m, C55N), 1529 (m, C–N); EI-MS (m/z): 258 (Mþ,
9), 230 (87), 127 (100), 103 (43), 84 (40), 77 (96).
1
3-Pr-6-(4-methylphenyl)-s-triazolo[3,4-b]-1,3,4-thiadiazines (3b). H NMR
(DMSO-d6) d: 1.06 (t, 3H, J ¼ 7.2 Hz, CH3CH2CH2), 1.61–2.08 (m, 2H,
CH3CH2CH2), 2.46 (s, 3H, CH3), 2.93 (t, 2H, J ¼ 7.2 Hz, CH3CH2CH2),
3.96 (s, 2H, SCH2), 7.46 (d, 2H, J ¼ 8.8 Hz, ArH), 7.78 (d, 2H, J ¼ 8.8 Hz,
ArH); IR (cm21) (KBr disc): 3036 (w, ArH), 2960, 2931 (w, CH3, CH2),
1610 (m, C55N), 1533 (m, C–N); EI-MS (m/z): 272 (Mþ, 20), 244 (100),
204 (11), 153 (10), 127 (87), 117 (17), 91 (33).
3-Pr-6-(4-chlorophenyl)-s-triazolo[3,4-b]-1,3,4-thiadiazines (3c). 1H NMR
(DMSO-d6) d: 1.06 (t, 3H, J ¼ 7.2 Hz, CH3CH2CH2), 1.66–2.12 (m, 2H,
CH3CH2CH2), 2.97 (t, 2H, J ¼ 7.2 Hz, CH3CH2 CH2), 3.99 (s, 2H, SCH2),
7.52 (d, 2H, J ¼ 8.8 Hz, ArH), 7.87 (d, 2H, J ¼ 8.8 Hz, ArH); IR (cm21
)
(KBr disc): 3063 (w, ArH), 2958, 2922 (w, CH3, CH2), 1588 (m, C55N),
1526 (m, C–N); EI-MS (m/z): 292 (Mþ, 5.4), 294 (2), 264 (54), 127 (100),
111 (25), 101 (45), 75 (44).
3-Pr-6-(4-bromophenyl)-s-triazolo[3,4-b]-1,3,4-thiadiazines (3d). 1H
NMR (DMSO-d6) d: 1.06 (t, 3H, J ¼ 7.2 Hz, CH3CH2CH2), 1.68–2.10
(m, 2H, CH3CH2CH2), 2.95 (t, 2H, J ¼ 7.2 Hz, CH3CH2 CH2), 4.00 (s, 2H,
SCH2), 7.48 (d, 2H, J ¼ 8.8 Hz, ArH), 7.86 (d, 2H, J ¼ 8.8 Hz, ArH); IR
(cm21) (KBr disc): 3059 (w, ArH), 2957, 2922 (w, CH3, CH2), 1583
(m, C55N), 1526 (m, C-N); EI-MS (m/z): 336 (Mþ, 11), 338 (11), 321 (2),
308 (96), 257 (10), 229 (3), 181 (9), 155 (23), 127 (94), 102 (51), 84 (29),
76 (22), 195 (6).
1
3-Bu-6-phenyl-s-triazolo[3,4-b]-1,3,4-thiadiazines (3e). H NMR (DMSO-
d6) d: 1.00 (t, 3H, J ¼ 7.2 Hz, CH3(CH2)2CH2), 1.12–2.10 (m, 4H,
CH3(CH2)2CH2), 2.98 (t, 3H, J ¼ 7.2 Hz, CH3(CH2)2CH2), 4.06 (s, 2H,
SCH2), 7.67 (s, 5H, ArH); IR (cm21) (KBr disc): 3045 (w, ArH), 2965,
2933 (w, CH3, CH2), 1599 (m, C55N), 1527 (m, C–N); EI-MS (m/z): 272
(Mþ, 7), 243 (21), 230 (100), 169 (8), 140 (13), 127 (28), 103 (6).
3-Bu-6-(4-methylphenyl)-s-triazolo[3,4-b]-1,3,4-thiadiazines (3f). 1H NMR
(DMSO-d6) d: 1.00 (t, 3H, J ¼ 7.2 Hz, CH3(CH2)2CH2), 1.12–2.12 (m, 4H,
CH3(CH2)2CH2), 2.37 (s, 3H, ArCH3), 2.97 (t, 3H, CH3(CH2)2CH2), 4.03
(s, 2H, SCH2), 7.67 (d, 2H, J ¼ 8.8 Hz, ArH), 7.82 (d, 2H, J ¼ 8.8 Hz,
ArH); IR (cm21) (KBr disc): 3038 (w, ArH), 2955, 2930 (w, CH3, CH2),
1594 (m, C55N), 1530 (m, C–N); EI-MS (m/z): 286 (Mþ, 14), 257 (21),
244 (100), 229 (4), 204 (9), 169 (8), 140 (30), 127 (81), 117 (14), 91 (33).
1
3-Bu-6-(4-chlorophenyl)-s-triazolo[3,4-b]-1,3,4-thiadiazines (3g). H NMR
(DMSO-d6) d: 1.00 (t, 3H, J ¼ 7.2 Hz, CH3(CH2)2CH2), 1.10–2.12 (m, 4H,
CH3(CH2)2CH2), 3.00 (t, 3H, CH3(CH2)2CH2), 4.00 (s, 2H, SCH2), 7.45